Serum paraoxonase activity and its relationship to diabetic complications in patients with non-insulin-dependent diabetes mellitus.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Metabolism: Clinical and Experimental

• Publication date

  1998-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0026-0495(98)90246-3PMID 9591753
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid peroxidation.

  1997cited by this paper
• Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.

  1997cited by this paper
• Paraoxonase gene polymorphism in Japanese subjects with coronary heart disease.

  1996cited by this paper
• The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture.

  1996cited by this paper
• Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes.

  1995cited by this paper
• Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial.

  1995cited by this paper
• Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins.

  1995cited by this paper
• A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease.

  1995cited by this paper
• The oxidation hypothesis of atherosclerosis.

  1994cited by this paper
• Is paraoxonase related to atherosclerosis.

  1993cited by this paper
• The molecular basis of the human serum paraoxonase activity polymorphism

  1993cited by this paper
• Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes.

  1993cited by this paper
• Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase.

  1993cited by this paper
• Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase.

  1993cited by this paper
• Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein

  1991cited by this paper
• Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus.

  1991cited by this paper
• Role of genetic polymorphism of human plasma paraoxonase/arylesterase in hydrolysis of the insecticide metabolites chlorpyrifos oxon and paraoxon.

  1988cited by this paper
• Lipoprotein metabolism in diabetes mellitus.

  1987cited by this paper
• The human serum paraoxonase/arylesterase polymorphism.

  1983cited by this paper
• Pharmacogenetics of drug metabolism

  1980cited by this paper

• Exploring the Proteomic Signature of Diabetic Nephropathy: Implications for Early Diagnosis and Treatment

  2025cites this paper
• Tetranectin and Paraoxonase 1 in Patients with Varying Stages of Heart Failure: A Cross-Sectional Analysis

  2025cites this paper
• Cholesterol Efflux Capacity and Anti-Oxidative Activity of High-Density Lipoprotein in Chronic Kidney Disease

  2025cites this paper
• The importance of paraoxonase 1 activity in chronic kidney disease

  2024cites this paper
• Genetic Determinants of High-density Lipoprotein Cholesterol Efflux Capacity: Insights from Paraoxonase 1 Polymorphisms

  2024cites this paper
• Genetic polymorphisms in the angiotensin converting enzyme, actinin 3 and paraoxonase 1 genes in women with diabetes and hypertension

  2023cites this paper
• Paraoxonase 1 and Chronic Kidney Disease: A Meta-Analysis

  2023cites this paper
• Modulatory Effect of Lifestyle-Related, Environmental and Genetic Factors on Paraoxonase-1 Activity: A Review

  2023cites this paper
• Hyperglycemia and Oxidative Stress: An Integral, Updated and Critical Overview of Their Metabolic Interconnections

  2023cites this paper
• Glucose-Related Traits and Risk of Migraine—A Potential Mechanism and Treatment Consideration

  2022cites this paper
• Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies

  2022cites this paper
• The role of abnormalities of lipoproteins and HDL functionality in small fibre dysfunction in people with severe obesity

  2021cites this paper
• Sex Difference Impacts on the Relationship between Paraoxonase-1 (PON1) and Type 2 Diabetes

  2020cites this paper
• The effect of thyroid hormone status on selected antioxidant parameters in patients with Graves' disease and active thyroid-associated orbitopathy.

  2020cites this paper
• The most effective polymorphisms of paraoxonase-1 gene on enzyme activity and concentration of paraoxonase-1 protein in type 2 diabetes mellitus patients and non-diabetic individuals: A systematic review and meta-analysis.

  2019cites this paper
• Elevated serum OxLDL is associated with progression of type 2 Diabetes Mellitus to diabetic retinopathy.

  2019cites this paper
• Paraoxonase activities and oxidative status during late pregnancy and postpartum period in dairy cattle with and without retained fetal membrane

  2018cites this paper
• Effects of selenium supplementation on paraoxonase-1 and myeloperoxidase activity in subjects with cardiovascular disease: the Selenegene study, a double-blind randomized controlled trial

  2018cites this paper
• Diabetic macular oedema: under‐represented in the genetic analysis of diabetic retinopathy

  2018cites this paper
• Paraoxonase 1 activities and its gene promoter single nucleotide polymorphisms (-108, -126, and -162) in diabetes mellitus

  2018cites this paper
• A case‐control study: The association of serum paraoxonase 1 activity and concentration with the development of type 2 diabetes mellitus

  2018cites this paper
• European versus Asian differences for the associations between paraoxonase‐1 genetic polymorphisms and susceptibility to type 2 diabetes mellitus

  2018cites this paper
• Type 2 Diabetes in Young Females Results in Increased Serum Amyloid A and Changes to Features of High Density Lipoproteins in Both HDL2 and HDL3

  2017cites this paper
• Type 2 Diabetes in Young Females Results in Increased Serum Amyloid

  2017cites this paper
• Chapter 9 – Paraoxonase 1 and Its Clinical Relevance

  2017cites this paper
• Deneysel Diyabet Oluşturulan ve Likopen Uygulanan Ratların Karaciğer Dokusunda Paraoksonaz Aktivitesinin İncelenmesi

  2017cites this paper
• Type 2 Diabetes in Young Females Results in Increased Serum Amyloid A and Changes to Features of High Density Lipoproteins in Both HDL 2 and HDL 3

  2017cites this paper
• Effects of pomegranate juice consumption on oxidative stress in patients with type 2 diabetes: a single-blind, randomized clinical trial

  2017cites this paper
• Relationship between MPV and paraoxonase-1 activity, brachial artery diameter and IMT in patients with diabetes mellitus

  2016cites this paper
• The effect of the paraoxonase 1 (PON1) T(-107)C polymorphism on serum PON1 activity in women is dependent on fatty acid intake.

  2016cites this paper
• Serum paraoxonase level and paraoxonase polymorphism in patients with acromegaly

  2016cites this paper
• Paraoxonase 1 gene polymorphisms and enzyme activities in coronary artery disease and its relationship to serum lipids and glycemia.

  2016cites this paper
• Zinc supplementation ameliorates glycoprotein components and oxidative stress changes in the lung of streptozotocin diabetic rats

  2016cites this paper
• A review about biomarkers for the investigation of vascular function and impairment in diabetes mellitus

  2016cites this paper
• Study of Paraoxonase, Catalase, HDL-Cholesterol and Malondialdehyde Levels in NIDDM

  2015cites this paper
• Paraoxonase-1 activity in type 2 diabetes mellitus with and without nephropathy

  2015cites this paper
• Association between Serum Paraoxonase 1 Activities (PONase/AREase) and L55M Polymorphism in Risk of Female Infertility

  2015cites this paper
• ДОСВІД ПРОВЕДЕННЯ ПРАКТИЧНИХ ЗАНЯТЬ З РОЗДІЛУ “ЗАХВОРЮВАННЯ СЛИЗОВОЇ ОБОЛОНКИ РОТОВОЇ ПОРОЖНИНИ” B УМОВАХ КРЕДИТНО-МОДУЛЬНОЇ СИСТЕМИ НАВЧАННЯ

  2015cites this paper
• How HDL protects LDL against atherogenic modification: paraoxonase 1 and other dramatis personae

  2015cites this paper
• Paraoxonase 1 polymorphisms (L55M and Q192R) as a genetic marker of diabetic nephropathy in youth with type 1 diabetes.

  2015cites this paper
• Association of cholesteryl ester transfer protein genotypes with paraoxonase-1 activity, lipid profile and oxidative stress in type 2 diabetes mellitus: A study in San Luis, Argentina

  2014cites this paper
• Lipoprotein Glycation in Diabetes Mellitus

  2014cites this paper
• CORRELATION BETWEEN SERUM PARAOXONASE ACTIVITY AND HIGH DENSITYLIPOPROTEIN LEVELS IN TYPE2 DIABETES PREDISPOSING TO ATEROSCLEROSIS

  2014cites this paper
• Implications of serum paraoxonase activity in obesity, diabetes mellitus, and dyslipidemia

  2013cites this paper
• Reduction of paraoxonase-1 activity may contribute the qualitative impairment of HDL particles in patients with type 2 diabetes.

  2013cites this paper
• Endothelial dysfunction - a major mediator of diabetic vascular disease.

  2013cites this paper
• Rôle de la Paraoxonase (PON1) dans l'activité anti-inflammatoire de HDL et sa modulation par la diète

  2013cites this paper
• There is no relationship between Paraoxonase serum level activity in women with endometriosis and the stage of the disease: an observational study

  2013cites this paper
• Potential association of paraoxonase-1, type 2 diabetes mellitus, and periodontitis.

  2013cites this paper
• Paraoxonase Activity as a Biochemical Indicator of Dyslipidaemia in Diabetes Mellitus Type 2 and Ischemic Heart Disease

  2013cites this paper
• Relationship of PON1 activity and hsCRP concentration with disease status in patients with type 2 diabetes mellitus with and without retinopathy

  2013cites this paper
• Protective effect of paraoxonase 1 gene variant L55M in retinal vein occlusion

  2013cites this paper
• Extra-virgin olive oil consumption reduces the age-related decrease in HDL and paraoxonase 1 anti-inflammatory activities.

  2013cites this paper
• Serum Paraoxonase Levels and PON1(192) Polymorphism in Type 2 Diabetes Mellitus Patients

  2013cites this paper
• High-density lipoprotein impedes glycation of low-density lipoprotein

  2013cites this paper
• The determination of Q192R polymorphism of paraoxonase 1 by using non-toxic substrate p-nitrophenylacetate

  2013cites this paper
• Endothelium White cell trafficking Vascular permeability Vascular tone Angiogenesis Inflammation Metabolism

  2013cites this paper
• PARAOXONASE 1 Gene Polymorphism Relationship with Type 2 Diabetes Mellitus

  2012cites this paper
• Paraoxonase activity in healthy, diabetic, and hemodialysis patients.

  2012cites this paper
• PARAOXONASE 1 Gene Polymorphism Relationship with Type 2 Diabetes Mellitus

  2012cites this paper
• HDL functionality

  2012cites this paper
• 6 Paraoxonase 1 ( PON 1 ) Activity , Polymorphisms and Coronary Artery Disease

  2012cites this paper
• Ethanol extract of Graptopetalum paraguayense upregulates paraoxonase 1 gene expression via an AKT/NF-κB-dependent pathway.

  2012cites this paper
• Effect of pomegranate juice on paraoxonase enzyme activity in patients with type 2 diabetes

  2012cites this paper
• Diabetic Microangiopathy - Etiopathogenesis, New Possibilities in Diagnostics and Management

  2012cites this paper
• Paraoxonase 1 (PON1) Activity, Polymorphisms and Coronary Artery Disease

  2012cites this paper
• The Human Paraoxonase Gene Cluster As a Target in the Treatment of Atherosclerosis

  2012cites this paper
• Are PON1 Q/R 192 and M/L 55 polymorphisms risk factors for diabetes complications in Turkish population?

  2011cites this paper
• Effect of vitamin e and selenium supplement on paraoxonase-1 activity, oxidized low density lipoprotein and antioxidant defense in diabetic rats.

  2011cites this paper
• Lovastatin enhances paraoxonase enzyme activity and quells low-density lipoprotein susceptibility to oxidation in type 2 diabetic nephropathy.

  2011cites this paper
• The Effects of Acute and Chronic Hyperglycemia on Serum Paraoxonase Activity

  2011influential citation
• Serum Paraoxonase (Arylesterase) activity in Type 2 Diabetes Mellitus and diabetic nephropathy

  2011cites this paper
• Responses Of paraoxonase 1 to dioxin-like pcb 126 ( 3,3',4,4',5-pentachlorobiphenyl): mechanisms and consequences

  2011cites this paper
• Role of JNK and c-Jun signaling pathway in regulation of human serum paraoxonase 1 gene transcription by berberine in human HepG2 cells.

  2011cites this paper
• [The effects of aminoguanidine on serum paraoxanase activity in streptozotocin- induced diabetic rats]

  2011cites this paper
• Antioxidant potential, paraoxonase 1, ceruloplasmin activity and C-reactive protein concentration in diabetic retinopathy

  2010cites this paper
• Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.

  2010cites this paper
• The genetics of vascular complications in diabetes mellitus.

  2010cites this paper
• Paraoxonase 1 R/Q alleles are associated with differential accumulation of saturated versus 20:5n3 fatty acid in human adipose tissue

  2010cites this paper
• Pitavastatin induces PON1 expression through p44/42 mitogen-activated protein kinase signaling cascade in Huh7 cells.

  2009cites this paper
• Variation in paraoxonase-1 activity and atherosclerosis

  2009cites this paper
• Relations of lysophosphatidylcholine in low-density lipoprotein with serum lipoprotein-associated phospholipase A2, paraoxonase and homocysteine thiolactonase activities in patients with type 2 diabetes mellitus.

  2009cites this paper
• Statin-paraoxonase Interactions During Statin Treatment

  2009cites this paper
• Effect of Regular Exercise on Serum Paraoxonase and Arylesterase Related to Age Increment in the Male Rat

  2009cites this paper
• Linkage analysis of albuminuria.

  2009cites this paper
• Low human paraoxonase predicts cardiovascular events in Japanese patients with type 2 diabetes

  2009influential citation
• Paraoxonase: a multifaceted biomolecule.

  2009cites this paper
• Polymorphism of the paraoxonase (PON-1) gene in the Slavonic part of the Kharkiv population

  2009cites this paper
• patient-oriented and epidemiological research Association of the novel cardiovascular risk factors paraoxonase 1 and cystatin C in type 2 diabetes

  2009cites this paper
• Atherosclerosis and oxidant stress : a new perspective

  2008cites this paper
• High-density lipoprotein cholesterol and paraoxonase 1 (PON1) genetics and serum PON1 activity in prepubertal children in Spain

  2008cites this paper
• High glucose induces transactivation of the human paraoxonase 1 gene in hepatocytes.

  2008cites this paper
• Diabetes and Oxidant Stress

  2008cites this paper
• The relationships between PON1 activity as well as oxLDL levels and coronary artery lesions in CHD patients with diabetes mellitus or impaired fasting glucose

  2008cites this paper
• Serum Paraoxonase-1 Activity in Dairy Cattle and its Association with Dystocia

  2008cites this paper
• [Serum paraoxonase activity and pon1 192 and pon1 55 polymorphisms in prepuberal children. the four provinces study].

  2007cites this paper
• Chronic renal failure in diabetic patients increases lipid risk factors for atherosclerosis.

  2007cites this paper
• Effect of PON1 polymorphism on HDL antioxidant potential is blunted with aging.

  2007cites this paper
• Paraoxonases are associated with intestinal inflammatory diseases and intracellularly localized to the endoplasmic reticulum.

  2007cites this paper
• The role of paraoxonase (PON) enzyme in the extent and severity of the coronary artery disease in type-2 diabetic patients

  2007cites this paper